Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Saturday, June 15, 2024 | Back issues
Courthouse News Service Courthouse News Service

Transgender Issues

BLS Pharma sued Inovio Pharmaceuticals and Genetronics for $77 million, claiming they refused to sell it proprietary elements of a needleless injector for testosterone injection after learning it would be used for transgender people, in Orange County Court.

SANTA ANA, Calif. — BLS Pharma sued Inovio Pharmaceuticals and Genetronics for $77 million, claiming they refused to sell it proprietary elements of a needleless injector for testosterone injection after learning it would be used for transgender people, in Orange County Court.

Categories / Business, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...